(23)(15) Clonitazene;Tiletamine and zolazepam or any salt thereof;

(24)other Crotonylnames fentanylfor ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide);the tiletamine and zolazepam combination product include:

(25)telazol; Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);

(26)other Cyclopropylnames fentanylfor (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);tiletamine include:

(27)2-(ethylamino)-2-(2-thienyl)-cyclohexanone; Dextromoramide;

H.other names for zolazepam include:

B.4-(2-fluorophenyl)-6,8-dihydro 1,3, 8-trimethylpyrazolo-[3,4-e](1,4)-diazepin-7(1H)-one, flupyrazapon.

No.(c) Nalorphine.

4(d) *HR31/R944*Any ~material, OFFICIALcompound, ~mixture 23/HR31/R944or PAGEpreparation 3(MCL\JAB)which (28)contains Diampromide;any quantity of ephedrine or pseudoephedrine, except for any product that contains any quantity of pseudoephedrine or ephedrine that is sold subject to the quantity restrictions authorized in Section 73-21-124.

(29)(e) Diethylthiambutene;Narcotic drugs.

(30)Any Difenoxin;material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:

(31)PAGE Dimenoxadol;34 (1) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;

(32)(2) Dimepheptanol;Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(33)(3) Dimethylthiambutene;Not more than one and eight-tenths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(34)(4) DioxaphetylNot butyrate;more than three hundred (300) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(35)(5) Dipipanone;Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams, or not more than twenty-five (25) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(36)(6) Ethylmethylthiambutene;Not more than fifty (50) milligrams of morphine, or any of its salts, per one hundred (100) milliliters PAGE 44 or per one hundred (100) grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(37)(f) Etonitazene;Anabolic steroids.

(38)Unless Etoxeridine;specifically exempted or listed in another schedule, any material, compound, mixture or preparation containing any quantity of any of the following anabolic steroids (any drug or hormonal substance chemically and pharmacologically related to testosterone other than estrogens, progestins, corticosteroids and dehydroepiandrosterone):

(39)(1) Fentanyl3beta,17-dihydroxy-5a-androstane; carbamate (ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate);

(40)(2) Fentanyl-related3alpha,17beta-dihydroxy-5a-androstane; substances, meaning any substance not otherwise listed under another schedule and for which no exemption or approval is in effect under Section 505 of the Federal Food, Drug, and Cosmetic Act [21 USC 355] that is structurally related to fentanyl by one or more of the following modifications:

(A)(3) Replacement5alpha-androstan-3,17-dione; of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

(B)(4) Substitution1-androstenediol in(3beta,17beta-dihydroxy-5alpha-androst-1-ene); or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;

H.(5) 1-androstenediol (3alpha,17beta-dihydroxy-5alpha-androst-1-ene);

B.(6) 4-androstenediol (3beta,17beta-dihydroxy-androst-4-ene);

No.(7) 5-androstenediol (3beta,17beta-dihydroxy-androst-5-ene);

4(8) *HR31/R944*1-androstenedione ~([5alpha]-androst-1-en-3, OFFICIAL17-dione); ~ 23/HR31/R944 PAGE 4(MCL\JAB) (C) Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;

(D)(9) Replacement4-androstenedione of(androst-4-en-3,17-dione); the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle;

and/or(10) (E)5-androstenedione Replacement(androst-5-en-3,17-dione); of the N-propionyl group by another acyl group.

(41)(11) 4-FluoroisobutyrylBolasterone fentanyl(7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide), also known as para-fluoroisobutyryl fentanyl);

(42)PAGE 2'-Fluoro54 ortho-fluorofentanyl(12) (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)Boldenone propionamide),(17beta-hydroxyandrost-1,4,-diene-3-one); also known as 2'-fluoro 2-fluorofentanyl;

(43)(13) FuranylBoldione fentanyl(androsta-1,4-diene-3,17-dione); (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide);

(44)(14) Furethidine;Calusterone (7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one);

(45)(15) Hydroxypethidine;Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one);

(46)(16) IsobutyrylDehydrochloromethyltestosterone fentanyl(4-chloro-17beta-hydroxy-17alpha-methylandrost-1,4-dien-3-one); (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide);

(47)(17) IsotonitazeneDesoxymethyltestosterone (N,N-diethyl-2-(2-(4(17alpha-methyl-5alpha-androst-2-en-17beta-ol, isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);also known as madol);

(48)(18) KetobemidoneDelta1-dihydrotestosterone (including(also theknown opticalas and1-testosterone) geometric(17beta-hydroxy-5alpha-androst-1-en-3-one); isomers);

(49)(19) Levomoramide;4-dihydrotestosterone (17beta-hydroxy-androstan-3-one);

H.(20) Drostanolone (17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one);

B.(21) Ethylestrenol (17alpha-ethyl-17beta-hydroxyestr-4-ene);

No.(22) Fluoxymesterone (9-fluoro-17alpha-methyl-11beta, 17beta-dihydroxyandrost-4-en-3-one);

4(23) *HR31/R944*Formebolone ~(2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1, OFFICIAL4-dien-3-one); ~ 23/HR31/R944 PAGE 5(MCL\JAB) (50) Levophenacylmorphan;

(51)PAGE Methoxyacetyl64 fentanyl(24) (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);Furazabol (17alpha-methyl-17beta-hydroxyandrostano[2,3-c]-furazan);

(52)(25) 4'-Methyl13beta-ethyl-17alpha-hydroxygon-4-en-3-one; acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);

(53)(26) 3-Methylfentanyl4-hydroxytestosterone (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);(4,17beta-dihydroxyandrost-4-en-3-one);

(54)(27) 3-Methylthiofentanyl4-hydroxy-19-nortestosterone (N-[3-methyl-1-(4,17beta-dihydroxy-estr-4-en-3-one); (2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide);

(55)(28) Morpheridine;Mestanolone (17alpha-methyl-17beta-hydroxy-5-androstan-3-one);

(56)(29) MPPPMesterolone (1-methyl-4-phenyl-4-propionoxypiperidine);(1alpha-methyl-17beta-hydroxy-[5alpha]-androstan-3-one);

(57)(30) MT-45Methandienone (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);(17alpha-methyl-17beta-hydroxyandrost-1,4-dien-3-one);

(58)(31) Noracymethadol;Methandriol (17alpha-methyl-3beta, 17beta-dihydroxyandrost-5-ene);

(59)(32) Norlevorphanol;Methasterone (2[alpha], 17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one;

(60)(33) Normethadone;Methenolone (1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one);

(61)(34) Norpipanone;17alpha-methyl-3beta, 17beta-dihydroxy-5a-androstane;

(62)(35) Ocfentanil17alpha-methyl-3alpha, (N-(2-fluorophenyl)-2-methoxy-N-17beta-dihydroxy-5a-androstane; (1-phenethylpiperidin-4-yl)acetamide);

(63)(36) Ortho-Fluoroacryl17alpha-methyl-3beta, fentanyl17beta-dihydroxyandrost-4-ene; (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);

(64)PAGE Ortho-Fluorobutyryl74 fentanyl(37) (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide),17alpha-methyl-4-hydroxynandrolone also(17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one); known as 2-fluorobutyryl fentanyl;

H.(38) Methyldienolone (17alpha-methyl-17beta-hydroxyestra-4,9(10)-dien-3-one);

B.(39) Methyltrienolone (17alpha-methyl-17beta-hydroxyestra-4,9-11-trien-3-one);

No.(40) Methyltestosterone (17alpha-methyl-17beta-hydroxyandrost-4-en-3-one);

4(41) *HR31/R944*Mibolerone ~(7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-en-3-one); OFFICIAL ~ 23/HR31/R944 PAGE 6(MCL\JAB) (65) Ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), also known as 2-fluorofentanyl;

(66)(42) Ortho-Fluoroisobutyryl17alpha-methyl-Delta1-dihydrotestosterone fentanyl(17b (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) (also known as 17-alpha-methyl-1-testosterone);

(67)(43) Ortho-MethylNandrolone acetylfentanyl(17beta-hydroxyestr-4-en-3-one); (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide), also known as 2-methyl acetylfentanyl;

(68)(44) Ortho-Methyl19-nor-4-androstenediol methoxyacetyl(3beta,17beta-dihydroxyestr-4-ene); fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) acetamide), also known as 2-methyl methoxyacetyl fentanyl;

(69)(45) Para-Chloroisobutyryl19-nor-4-androstenediol fentanyl(3a,17beta-dihydroxyestr-4-ene); (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

(70)(46) Para-Fluorobutyryl19-nor-5-androstenediol fentanyl(3beta,17beta-dihydroxyestr-5-ene); (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);

(71)(47) Para-Fluorofentanyl19-nor-5-androstenediol (N-(4-fluorophenyl)(3alpha,17beta-dihydroxyestr-5-ene); -N-[1-(2-phenylethyl)-4-piperidinyl]propanamide);

(72)(48) Para-Fluoro19-nor-4,9(10)-androstadienedione furanyl(estra-4,9(10)-diene3,17-dione, fentanyl19-norandrosta-4,9(10)-diene-3,17-dione); N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4-yl)furan-2-carboxamide);

(73)PAGE Para-Methoxybutyryl84 fentanyl(49) (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);19-nor-4-androstenedione (estr-4-en-3,17-dione);

(74)(50) Para-Methylfentanyl19-nor-5-androstenedione (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide),(estr-5-en-3,17-dione); also known as 4-methylfentanyl);

H.(51) Norbolethone (13beta,17alpha-diethyl-17beta-hydroxygon-4-en-3-one);

B.(52) Norclostebol (4-chloro-17beta-hydroxyestr-4-en-3-one);

No.(53) Norethandrolone (17alpha-ethyl-17beta-hydroxyestr-4-en-3-one);

4(54) *HR31/R944*Normethandrolone ~(17alpha-methyl-17beta-hydroxyestr-4-en-3-one); OFFICIAL ~ 23/HR31/R944 PAGE 7(MCL\JAB) (75) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);

(76)(55) Phenadoxone;Oxandrolone (17alpha-methyl-17beta-hydroxy-2-oxa-[5alpha]-androstan-3-one);

(77)(56) Phenampromide;Oxymesterone (17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one);

(78)(57) Phenomorphan;Oxymetholone (17alpha-methyl-2-hydroxymethylene-17beta-hydroxy-[5alpha]- androstan-3-one);

(79)(58) Phenoperidine;Prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole) (59) Stanozolol (17alpha-methyl-17beta-hydroxy-[5alpha]-androst-2-eno[3,2-c]- pyrazole);

(80)(60) PhenylStenbolone fentanyl(17beta-hydroxy-2-methyl-[5alpha]-androst-1-en-3-one); (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide), also known as benzoyl fentanyl;

(81)PAGE Piritramide;94 (61) Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);

(82)(62) Proheptazine;Testosterone (17beta-hydroxyandrost-4-en-3-one);

(83)(63) Properidine;Tetrahydrogestrinone (13beta,17alpha-diethyl-17beta-hydroxygon-4,9,11-trien-3-one);

(84)(64) Propiram;Trenbolone (17beta-hydroxyestr-4,9,11-trien-3-one);

(85)(65) Racemoramide;Any salt, ester, or ether of a drug or substance described in this paragraph.

(86)Except Tetrahydrofuranylsuch fentanylterm (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-does carboxamide);not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the Secretary of Health and Human Services for such administration.

(87)If Thiofentanylany (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);person prescribes, dispenses, or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph.

(88)(g) ThiofuranylAny fentanylmaterial, (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide),compound, alsomixture knownor aspreparation 2-thiofuranylwhich fentanylcontains any quantity of buprenorphine or thiopheneits fentanyl;salts.

(89)(h) Tilidine;Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product.

(90)(i) Trimeperidine;Any material, compound, mixture, or preparation which contains any quantity of Tianeptine (7-((3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]th PAGE 10 iazepin-11-yl)amino)heptanoic acid) or its salts, isomers, salts of isomers, sulfate, free acid or derivative thereof.

(91)(B) U-47700,Any (3,4-dichloro-N-material, H.compound, mixture or preparation which contains any quantity of a Schedule III controlled substance other than butalbital, and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 8(MCL\JAB) [2-(dimethylamino)cyclohexyl]-N-methylbenzamide);

(92) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide).

(93) Tianeptine and any salt, sulfate, free acid, or other preparation of Tianeptine, and any salt, sulfate, free acid, compound, derivative, precursor, or preparation thereof which is substantially chemically equivalent or identical with Tianeptine.

(c) Opium derivatives.

Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Acetorphine;

(2) Acetyldihydrocodeine;

(3) Benzylmorphine;

(4) Codeine methylbromide;

(5) Codeine-N-Oxide;

(6) Cyprenorphine;

(7) Desomorphine;

(8) Dihydromorphine;

(9) Drotebanol;

(10) Etorphine (except hydrochloride salt);

(11) Heroin;

(12) Hydromorphinol;

(13) Methyldesorphine;

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 9(MCL\JAB) (14) Methyldihydromorphine;

(15) Monoacetylmorphine;

(16) Morphine methylbromide;

(17) Morphine methylsulfonate;

(18) Morphine-N-Oxide;

(19) Myrophine;

(20) Nicocodeine;

(21) Nicomorphine;

(22) Normorphine;

(23) Pholcodine;

(24) Thebacon.

(d) Hallucinogenic substances.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric) and salts of isomers, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Alpha-ethyltryptamine;

(2) 4-bromo-2,5-dimethoxy-amphetamine;

(3) 4-bromo-2,5-dimethoxyphenethylamine;

(4) 2,5-dimethoxyamphetamine;

(5) 2,5-dimethoxy-4-ethylamphetamine (DOET);

(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7);

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 10(MCL\JAB) (7) 4-methoxyamphetamine;

(8) 5-methoxy-3,4-methylenedioxy-amphetamine;

(9) 4-methyl-2,5-dimethoxy-amphetamine;

(10) 3,4-methylenedioxy amphetamine;

(11) 3,4-methylenedioxymethamphetamine (MDMA);

(12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA);

(13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy MDA, N-OHMDA, and N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine);

(14) 3,4,5-trimethoxy amphetamine;

(15) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT);

(16) Alpha-methyltryptamine (also known as AMT);

(17) Bufotenine;

(18) Diethyltryptamine;

(19) Dimethyltryptamine;

(20) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT);

(21) Ibogaine;

(22) Lysergic acid diethylamide (LSD);

(23) (A) Marijuana (Hemp as defined and regulated under Sections 69-25-201 through 69-25-221 and Cannabidiol contained in a legend drug product approved by the Federal Food and Drug Administration or obtained under Section 41-29-136 are exempt under Schedule I);

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 11(MCL\JAB) (B) Hashish;

(24) Mescaline;

(25) Parahexyl;

(26) Peyote;

(27) N-ethyl-3-piperidyl benzilate;

(28) N-methyl-3-piperidyl benzilate;

(29) Psilocybin;

(30) Psilocyn;

(31) Tetrahydrocannabinols, meaning tetrahydrocannabinols contained in a plant of the genus Cannabis (cannabis plant), as well as the synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant such as the following:

(A) 1 cis or trans tetrahydrocannabinol;

(B) 6 cis or trans tetrahydrocannabinol;

(C) 3,4 cis or trans tetrahydrocannabinol.

(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of atomic positions, are covered.) ("Tetrahydrocannabinols" excludes dronabinol and nabilone.) For purposes of this paragraph, tetrahydrocannabinols do not H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 12(MCL\JAB) include hemp or hemp products regulated under Sections 69-25-201 through 69-25-221.

However, the following products are exempted from control:

(i) THC-containing industrial products made from cannabis stalks (e.g., paper, rope and clothing);

(ii) Processed cannabis plant materials used for industrial purposes, such as fiber retted from cannabis stalks for use in manufacturing textiles or rope;

(iii) Animal feed mixtures that contain sterilized cannabis seeds and other ingredients (not derived from the cannabis plant) in a formula designed, marketed and distributed for nonhuman consumption;

(iv) Personal care products that contain oil from sterilized cannabis seeds, such as shampoos, soaps, and body lotions (if the products do not cause THC to enter the human body);

(v) Hemp as regulated under Sections 69-25-201 through 69-25-221;

and (vi) Any product derived from the hemp plant designed for human ingestion and/or consumption that is approved by the United States Food and Drug Administration;

(32) Phencyclidine;

(33) Ethylamine analog of phencyclidine (PCE);

(34) Pyrrolidine analog of phencyclidine (PHP, PCPy);

(35) Thiophene analog of phencyclidine;

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 13(MCL\JAB) (36) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy);

(37) 4-methylmethcathinone (mephedrone);

(38) 3,4-methylenedioxypyrovalerone (MDPV);

(39) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine (2C-E);

(40) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D);

(41) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);

(42) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);

or 2,5-dimethoxy-4-iodophenethylamine;

(43) 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);

(44) 2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);

(45) 2-(2,5-dimethoxyphenyl)ethanamine (2C-H);

(46) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine (2C-N);

(47) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);

(48) 3,4-methylenedioxy-N-methylcathinone(methylone);

(49) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe;

2C-B-NBOMe;

25B;

Cimbi-36);

(50) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe;

2C-C-NBOMe;

25C;

Cimbi-82);

(51) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 14(MCL\JAB) N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe;

2C-I-NBOMe;

25I;

Cimbi-5);

(52) 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1, 4-benzodiazepin-2-one (also known as Phenazepam);

(53) 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8, 11,12-tetraazatricyclo[8.3.0.0]trideca-2(6),4,7,10,12-pentaene (also known as Etizolam);

(54) Salvia divinorum;

(55) Synthetic cannabinoids.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a synthetic cannabinoid found in any of the following chemical groups, whether or not substituted to any extent, or any of those groups which contain any synthetic cannabinoid salts, isomers, or salts of isomers, whenever the existence of such salts, isomers, or salts of isomers is possible within the specific chemical designation, including all synthetic cannabinoid chemical analogues in such groups:

(A) (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol (also known as HU-210 or 1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol);

(B) Naphthoylindoles and naphthylmethylindoles, being any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane, whether or not substituted H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 15(MCL\JAB) in the indole ring to any extent, or in the naphthyl ring to any extent;

(C) Naphthoylpyrroles, being any compound structurally derived from 3-(1-naphthoyl)pyrrole, whether or not substituted in the pyrrole ring to any extent, or in the naphthyl ring to any extent;

(D) Naphthylmethylindenes, being any compound structurally derived from 1-(1-naphthylmethyl)indene, whether or not substituted in the indene ring to any extent or in the naphthyl ring to any extent;

(E) Phenylacetylindoles, being any compound structurally derived from 3-phenylacetylindole, whether or not substituted in the indole ring to any extent or in the phenyl ring to any extent;

(F) Cyclohexylphenols, being any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol, whether or not substituted in the cyclohexyl ring to any extent or in the phenolic ring to any extent;

(G) Benzoylindoles, whether or not substituted in the indole ring to any extent or in the phenyl ring to any extent;

(H) Adamantoylindoles, whether or not substituted in the indole ring to any extent or in the adamantoyl ring system to any extent;

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 16(MCL\JAB) (I) Tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives, except where contained in cannabis or cannabis resin;

(J) 3-Cyclopropylmethanone indole or 3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl rings to any extent;

(K) Quinolinyl ester indoles, being any compound structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl ester, whether or not substituted in the indole ring to any extent or the quinolone ring to any extent;

(L) 3-carboxamide-1H-indazoles, whether or not substituted in the indazole ring to any extent and substituted to any degree on the carboxamide nitrogen and 3-carboxamide-1H-indoles, whether or not substituted in the indole ring to any extent and substituted to any degree on the carboxamide nitrogen;

(M) Cycloalkanemethanone Indoles, whether or not substituted at the nitrogen atom on the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cycloalkane ring to any extent;

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 17(MCL\JAB) (56) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, also known as NM2201 or CBL2201;

(57) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3-carboxamide, also known as 5F-CUMYL-P7AICA;

(58) 1-(4-methoxyphenyl)-N-methylpropan-2-amine, also known as para-methoxymethamphetamine or PMMA.

(e) Depressants.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Clonazolam, 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine;

(2) Flualprazolam, 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4 ]benzodiazepine;

(3) Flubromazepam, 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one;

(4) Flubromazolam, H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 18(MCL\JAB) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepin;

(5) Gamma-hydroxybutyric acid (other names include:

GHB, gamma-hydroxybutyrate;

4-hydroxybutyrate;

4-hydroxybutanoic acid;

sodium oxybate;

sodium oxybutyrate);

(6) Mecloqualone;

(7) Methaqualone.

(f) Stimulants.

Any material, compound, mixture or preparation which contains any quantity of the following central nervous system stimulants including optical salts, isomers and salts of isomers unless specifically excepted or unless listed in another schedule:

(1) Aminorex;

(2) N-benzylpiperazine (also known as BZP and 1-benzylpiperazine);

(3) Cathinone;

(4) Fenethylline;

(5) Methcathinone;

(6) 4-methylaminorex (also known as 2-amino-4-methyl-5-phenyl-2-oxazoline);

(7) N-ethylamphetamine;

(8) Any material, compound, mixture or preparation which contains any quantity of N,N-dimethylamphetamine.

(Other names include:

N,N,-alpha-trimethyl-benzeneethanamine and N,N-alpha-trimethylphenethylamine);

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 19(MCL\JAB) (9) Synthetic cathinones.

(A) Unless listed in another schedule, any compound other than bupropion that is structurally derived from 2-Amino-1-phenyl-1-propanone by modification in any of the following ways:

(i) By substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;

(ii) By substitution at the 3-position with an alkyl substituent;

(iii) By substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.

(B) The compounds covered in this paragraph (9) include, but are not limited to, any material, compound, mixture or preparation which contains any quantity of a synthetic cathinone found in any of the following compounds, whether or not substituted to any extent, or any of these compounds which contain any synthetic cathinone, or salts, isomers, or salts of isomers, whenever the existence of such salts, isomers or salts of isomers is possible, unless specifically excepted or listed in another schedule:

(i) 4-methyl-N-ethylcathinone ("4-MEC");

(ii) 4-methyl-alpha-pyrrolidinopropiophenone ("4-MePPP");

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 20(MCL\JAB) (iii) Alpha-pyrrolidinopentiophenone ("α-PVP");

(iv) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one ("butylone");

(v) 2-(methylamino)-1-phenylpentan-1-one ("pentedrone");

(vi) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one ("pentylone");

(vii) 4-fluoro-N-methylcathinone ("4-FMC");

(viii) 3-fluoro-N-methylcathinone ("3-FMC");

(ix) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one ("naphyrone");

(x) Alpha-pyrrolidinobutiophenone ("α-PBP");

and (xi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one (N-ethylpentylone, ephylone).

H.Further, amend by striking the title in its entirety and inserting in lieu thereof the following:

B.AN ACT TO AMEND SECTION 41-29-117, MISSISSIPPI CODE OF 1972, TO INCLUDE TIANEPTINE AS A SCHEDULE III DRUG;

No.AND FOR RELATED PURPOSES.

4SS36\HB4A.2J *HR31/R944*Eugene ~S. OFFICIAL ~ 23/HR31/R944 ST:

Tianeptine;Clarke Secretary of the Senate PAGE 11

include in Schedule I PAGE 21(MCL\JAB) controlled substance list.